Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C) [Phase 2]
Phase 2 MATCH subprotocol Z1C evaluates palbociclib in cancers with CDK4/CDK6 amplification; results have been posted and the trial is curre…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A) [Phase 2]
Phase 2 MATCH subprotocol evaluating afatinib for cancers with EGFR genetic alterations; results have been posted and the trial is active bu…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas [Phase 1]
Phase 1 trial of the indenoisoquinoline LMP744 in adults with relapsed solid tumors and lymphomas has completed, with results posted in Dece…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies [Phase 2]
This Phase 2 trial studied the combination of lenalidomide and ipilimumab after stem cell transplantation in patients with hematologic or ly…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Mediastinal Recurrence of Lympho-proliferative Disorders: a Biopsy is Needed
The completed clinical trial NCT06714045 on mediastinal recurrence of lympho-proliferative disorders notes that a biopsy is needed for asses…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System [Phase 1, Phase 2]
Takeda's TAK-981 was studied in Phase 1/2 trials for advanced solid tumors and hematologic malignancies, but the study was terminated with r…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer Patients
The In4M study, a trial evaluating four methods to assess physical function in cancer patients, has completed, including participants with b…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Malignancies [Phase 1]
Pfizer's Maplirpacept (PF-07901801) Phase 1 trial in hematologic malignancies (lymphoma and multiple myeloma) has completed enrollment/statu…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects [Phase 1]
Phase 1 safety and pharmacokinetic data for RRx-001 in cancer patients; the trial (solid tumors and lymphomas) has completed and results wer…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma [Phase 1]
Phase 1 dose-escalation and expansion study of ASP4132 in patients with lymphoma and solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer [Phase 1]
Phase 1 study of BRD/BET inhibitors BMS-986158 and BMS-986378 in pediatric cancers has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy [NA]
Completed clinical trial assessing the impact of chemotherapeutic treatments in patients aged 75 and older with lymphoid hematological malig…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation [NA]
Completed clinical trial comparing BeEAM versus CEM conditioning regimens in lymphoma patients undergoing autologous hematopoietic cell tran…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy [Phase 2]
This Phase 2 trial assesses the safety and immunogenicity of the Moderna COVID-19 vaccine (mRNA-1273) in patients with solid tumors and hema…
-
CLINICAL_TRIALS trial_result · 2024-08-23Clinical Trial Update: Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating a combination of post-transplant cyclophosphamide, abatacept, vedolizumab, and baricitinib to prevent graft…
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: A Study of Chinese Adults With Lymphoma
This entry notes the completion of a Takeda-sponsored clinical study evaluating a treatment for lymphoma in Chinese adults.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: ACY-1215 for Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Clinical trial update for ACY-1215 (ricolinostat) in relapsed/refractory lymphoid malignancies reports Phase 1/2 results; the study has been…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports dose-escalation and preliminary efficacy findings for intratumoral mRNA-2416 as a standalone therapy and …
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss [Phase 1]
Phase 1 study of AG-270 in participants with MTAP-deleted advanced solid tumors or lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001) [Phase 1]
Phase 1 study of MK-2118 given as intratumoral monotherapy or in combination with pembrolizumab, and of subcutaneous MK-2118 in combination …
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Comparative Quantification of MTX and Its Metabolites Post Glucarpidase
This completed clinical trial evaluated the pharmacokinetics of methotrexate and its metabolites after glucarpidase administration in patien…
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. [Phase 1]
A Phase 1 study evaluating GRC 54276 in participants with advanced solid tumors and lymphomas is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 multiple ascending dose study of milademetan in adults with advanced solid tumors or lymphomas has completed, and results have been …
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma [Phase 2]
Phase 2 trial evaluating whether a hypertension intervention reduces osteonecrosis in children with acute lymphoblastic leukemia or lymphoma…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating the TEAM conditioning regimen (thiotepa, etoposide, cytarabine (Cytosar), melphalan) for autologous stem…